Galderma Group Ltd header image

Galderma Group Ltd

GALD

Equity

ISIN CH1335392721 / Valor 133539272

SIX Swiss Exchange (2026-01-30)

CHF 143.90+0.70%

Galderma Group Ltd
UMushroom community rating:

4.33 3 votes No rating yet

NegativeNeutralPositive

About company

Galderma Group Ltd is a leading company in the dermatology sector, focusing exclusively on this field for over 40 years. The company specializes in developing, manufacturing, and marketing a wide range of dermatological treatments and solutions. Galderma's product portfolio includes therapeutic dermatology products, dermatological skincare, and injectable aesthetic treatments, catering to a diverse range of skin health needs. With a global presence, the company operates research and development centers and manufacturing facilities strategically located around the world. Galderma is dedicated to advancing the field of dermatology through continuous innovation and science-based solutions, aiming to enhance the quality of life for patients with various skin conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

26.7%1Y

%3Y

%5Y

Performance

35.5%1Y

31.2%3Y

31.2%5Y

Volatility

43735 M

Market cap (USD)

387,513

Daily traded volume (Shares)

100.6 / 98.35

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.33

3 votes

Performance:

4.00

Innovation:

4.00

Society:

3.00

Nature:

2.67

Laura Bischofberger

Switzerland, 12 Jun 2024

New kid on the block, lets see where they go after they IPO.

Hein Sweerts de Landas

Switzerland, 12 Jun 2024

It's the trend, personal beautification. Online: photoshop, real world: Galderma!

Lea Katunaric

Switzerland, 12 Jun 2024

Was never too keen on this type of procedures.

EQUITIES OF THE SAME SECTOR

Embla Medical hf

Embla Medical hf Valor: 1060135

Annual Return

-50%0%+50%

Risk level

110

0.32%DKK 31.70

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252584

Annual Return

-50%0%+50%

Risk level

110

1.38%DKK 36.85

EssilorLuxottica SA

EssilorLuxottica SA Valor: 497537

Annual Return

-50%0%+50%

Risk level

110

1.30%EUR 257.90

bioMerieux SA

bioMerieux SA Valor: 38147803

Annual Return

-50%0%+50%

Risk level

110

0.05%EUR 97.80

Ramsay Generale de Sante SA

Ramsay Generale de Sante SA Valor: 1247709

Annual Return

-50%0%+50%

Risk level

110

-1.47%EUR 10.05

Orion Oyj

Orion Oyj Valor: 2553360

Annual Return

-50%0%+50%

Risk level

110

-1.00%EUR 69.20

Siemens Healthineers AG

Siemens Healthineers AG Valor: 40652181

Annual Return

-50%0%+50%

Risk level

110

0.29%EUR 42.17

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA Valor: 332902

Annual Return

-50%0%+50%

Risk level

110

1.16%EUR 47.21

Fresenius Medical Care AG

Fresenius Medical Care AG Valor: 520878

Annual Return

-50%0%+50%

Risk level

110

1.28%EUR 37.91

Evolent Health Inc

Evolent Health Inc Valor: 28153126

Annual Return

-50%0%+50%

Risk level

110

-0.93%USD 3.21

SIX

FactSet

Clearbit

Logos provided by Clearbit